Literature DB >> 26691847

Impulsivity and polysubstance use: A systematic comparison of delay discounting in mono-, dual-, and trisubstance use.

Lara Moody1, Christopher Franck1, Laura Hatz1, Warren K Bickel1.   

Abstract

Understanding the association between polysubstance use and impulsivity is pertinent to treatment planning and efficacy. Delay discounting, a measure of impulsivity, supplies the rate at which a reinforcer loses value as the temporal delay to its receipt increases. Excessive delay discounting has been widely observed among drug-using individuals, though the impact of using more than 1 substance has been only minimally studied. Here, after controlling for demographic variables, we systematically compared delay discounting in community controls, heavy smokers, and alcohol- and cocaine-dependent individuals to assess the impact of non-, mono-, dual-, and trisubstance use. All substance-using groups discounted significantly more than did community controls (p < .05). Additionally, groups that smoked cigarettes in addition to another substance dependency discounted significantly more than did the group that smoked cigarettes only (p < .05). Last, trisubstance users who were alcohol-dependent, cocaine-dependent, and heavy cigarette smokers discounted significantly more than did heavy smokers (p < .01). However, trisubstance users did not discount significantly more than did any dual-substance group. Trisubstance use was associated with greater impulsivity than was monosubstance smoking but exhibited no greater impulsivity than did dual-substance use, suggesting a ceiling effect on discounting when more than 2 substances are in use. The present study suggests that smokers who engage in additional substance use may experience worse treatment outcomes, given that excessive discounting is predictive of poor therapeutic outcomes in several studies. PsycINFO Database Record (c) 2016 APA, all rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26691847      PMCID: PMC4821755          DOI: 10.1037/pha0000059

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  20 in total

1.  Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls.

Authors:  N M Petry
Journal:  Psychopharmacology (Berl)       Date:  2001-03       Impact factor: 4.530

2.  Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls.

Authors:  Sarah H Heil; Matthew W Johnson; Stephen T Higgins; Warren K Bickel
Journal:  Addict Behav       Date:  2005-10-19       Impact factor: 3.913

3.  A systematic assessment of delay discounting in relation to cocaine and nicotine dependence.

Authors:  Olaya García-Rodríguez; Roberto Secades-Villa; Sara Weidberg; Jin Ho Yoon
Journal:  Behav Processes       Date:  2013-07-17       Impact factor: 1.777

4.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

Review 5.  The behavioral- and neuro-economic process of temporal discounting: A candidate behavioral marker of addiction.

Authors:  Warren K Bickel; Mikhail N Koffarnus; Lara Moody; A George Wilson
Journal:  Neuropharmacology       Date:  2013-06-24       Impact factor: 5.250

6.  Neuropsychological function and delay discounting in methamphetamine-dependent individuals.

Authors:  William F Hoffman; Meredith Moore; Raymond Templin; Bentson McFarland; Robert J Hitzemann; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

7.  Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals.

Authors:  Scott F Coffey; Gregory D Gudleski; Michael E Saladin; Kathleen T Brady
Journal:  Exp Clin Psychopharmacol       Date:  2003-02       Impact factor: 3.157

8.  Delay discounting in current and former marijuana-dependent individuals.

Authors:  Matthew W Johnson; Warren K Bickel; Forest Baker; Brent A Moore; Gary J Badger; Alan J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2010-02       Impact factor: 3.157

9.  Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards.

Authors:  G J Madden; N M Petry; G J Badger; W K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  1997-08       Impact factor: 3.157

Review 10.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

View more
  22 in total

Review 1.  Age and impulsive behavior in drug addiction: A review of past research and future directions.

Authors:  Evangelia Argyriou; Miji Um; Claire Carron; Melissa A Cyders
Journal:  Pharmacol Biochem Behav       Date:  2017-08-01       Impact factor: 3.533

2.  Neurocognitive dysfunction in addiction: Testing hypotheses of diffuse versus selective phenotypic dysfunction with a classification-based approach.

Authors:  Warren K Bickel; Lara N Moody; Celia R Eddy; Christopher T Franck
Journal:  Exp Clin Psychopharmacol       Date:  2017-08       Impact factor: 3.157

Review 3.  Differences in decision-making as a function of drug of choice.

Authors:  Joshua L Gowin; Matthew E Sloan; Vijay A Ramchandani; Martin P Paulus; Scott D Lane
Journal:  Pharmacol Biochem Behav       Date:  2017-09-18       Impact factor: 3.533

4.  A second type of magnitude effect: Reinforcer magnitude differentiates delay discounting between substance users and controls.

Authors:  Alexandra M Mellis; Alina E Woodford; Jeffrey S Stein; Warren K Bickel
Journal:  J Exp Anal Behav       Date:  2017-01       Impact factor: 2.468

5.  Persisting on the past: Cross-sectional and prospective associations between sunk cost propensity and cannabis use.

Authors:  Michael J Sofis; Shea M Lemley; Alan J Budney; Catherine Stanger; David P Jarmolowicz
Journal:  Exp Clin Psychopharmacol       Date:  2019-05-09       Impact factor: 3.157

6.  Striatal bases of temporal discounting in early adolescents.

Authors:  Kristen R Hamilton; Jason F Smith; Stefanie F Gonçalves; Jazlyn A Nketia; Olivia N Tasheuras; Mark Yoon; Katya Rubia; Theresa J Chirles; Carl W Lejuez; Alexander J Shackman
Journal:  Neuropsychologia       Date:  2020-05-11       Impact factor: 3.139

7.  Neurocognition and inhibitory control in polysubstance use disorders: Comparison with alcohol use disorders and changes with abstinence.

Authors:  Thomas P Schmidt; David L Pennington; Stephanie L Cardoos; Timothy C Durazzo; Dieter J Meyerhoff
Journal:  J Clin Exp Neuropsychol       Date:  2016-10-03       Impact factor: 2.475

8.  The relationship between delay discounting and alcohol dependence in individuals with and without comorbid psychopathology.

Authors:  Joshua Gowin; Matthew E Sloan; Julia E Swan; Reza Momenan; Vijay A Ramchandani
Journal:  Psychopharmacology (Berl)       Date:  2018-11-19       Impact factor: 4.530

9.  Steep delay discounting and addictive behavior: a meta-analysis of continuous associations.

Authors:  Michael Amlung; Lana Vedelago; John Acker; Iris Balodis; James MacKillop
Journal:  Addiction       Date:  2016-09-01       Impact factor: 6.526

10.  E-cigarette use among young adults: A latent class analysis examining co-use and correlates of nicotine vaping.

Authors:  H Isabella Lanza; Gabriella Motlagh; Monica Orozco
Journal:  Addict Behav       Date:  2020-06-26       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.